News - Page 12 of 15 - Lymphoma Australia

published September 13, 2016
Your chance to help The following treatments for lymphoma will be considered at the next Pharmaceutical Be
published April 27, 2016
  Rethink on chemotherapy as Government funds new medicine to fight lymphoma Thousands of Australians
published April 22, 2016
PET Determines Effectiveness of Hodgkin Lymphoma Treatment – Patients with Hodgkin lymphoma (HL) who underg
published April 4, 2016
A new time-saving subcutaneous formulation of MabThera has been approved by the PBS in Australia for the treat
published April 1, 2016
EMA action brings Nivolumab closer to first hematology approval Click here to read more
published April 1, 2016
Booming knowledge of how geonomics works for Cutaneous T cell Lymphoma is likely to lead to new, more targeted
published March 18, 2016
NEW AGENTS TRANSFORM THE TREATMENT OF NHLClick here to read more Advances for Non Hodgkin Lymphoma
published March 9, 2016
Reduced Intensity Salvage Allo-HCT Effective for Follicular LymphomaReduced intensity allogeneic hematopoietic
published February 4, 2016
 CAR T-cell therapy poised to shift hematologic malignancies treatment paradigmClick here for more inform
published February 1, 2016
New drug causes cancer to "melt away" in patients with advanced CLLIt worked in 79% of patients. Rea
published January 26, 2016
http://www.bloodjournal.org/content/127/2/181?rss=1&sso-checked=true
published December 17, 2015
Our Faces of Change – Thank you! Lymphoma Australia was founded in 2003 by a group of volunteers and became

Contact Lymphoma Australia Today!

Please note:
Lymphoma Australia staff are only able to reply to emails sent in English language.

Useful Definitions

  • Refractory: This means the lymphoma does not get better with treatment. The treatment didn’t work as hoped.
  • Relapsed: This means the lymphoma came back after being gone for a while after treatment.
  • 2nd line treatment: This is the second treatment you get if the first one didn’t work (refractory) or if the lymphoma comes back (relapse).
  • 3rd line treatment: This is the third treatment you get if the second one didn’t work or the lymphoma comes back again.
  • Approved: Available in Australia and listed by the Therapeutics Goods Administration (TGA).
  • Funded: Costs are covered for Australian citizens. This means if you have a Medicare card, you shouldn’t have to pay for the treatment.[WO7]

You need healthy T-cells to make CAR T-cells. For this reason, CAR T-cell therapy cannot be used if you have a T-cell lymphoma – yet.

For more information on CAR T-cells and T-cell lymphoma click here. 

Special Note: Although your T-cells are removed from your blood for CAR T-cell therapy, most of our T-cells live outside of our blood – in our lymph nodes, thymus, spleen and other organs.